These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21794327)

  • 1. [Antimalarials: an update in rheumatic diseases].
    Jiménez Palop M
    Reumatol Clin; 2006 Jul; 2(4):190-201. PubMed ID: 21794327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of exercise in the rehabilitation of patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
    Strömbeck B; Jacobsson LT
    Curr Opin Rheumatol; 2007 Mar; 19(2):197-203. PubMed ID: 17278938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials.
    Gonzalez-Lopez L; Gamez-Nava JI; Jhangri G; Russell AS; Suarez-Almazor ME
    J Rheumatol; 2000 Jan; 27(1):41-6. PubMed ID: 10648016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
    Breda L; Nozzi M; De Sanctis S; Chiarelli F
    Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A; Talal N
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatologic manifestations of rheumatic disorders.
    McCauliffe DP; Sontheimer RD
    Prim Care; 1993 Dec; 20(4):925-41. PubMed ID: 8310089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy and autoimmunity.
    Bernatsky S; Ramsey-Goldman R; Clarke A
    Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.
    Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SYNTHETIC ANTIMALARIALS IN RHEUMATOLOGICAL THERAPEUTICS].
    ROBERTD ESHOUGUES J; LEBEURRE R
    Lille Med; 1964 Apr; 9():383-8. PubMed ID: 14144037
    [No Abstract]   [Full Text] [Related]  

  • 11. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
    Rosenthal M
    J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of exercise training in patients with pediatric rheumatic diseases.
    Gualano B; Pinto AL; Perondi MB; Roschel H; Sallum AM; Hayashi AP; Solis MY; Silva CA
    Rev Bras Reumatol; 2011; 51(5):490-6. PubMed ID: 21953000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term followup of children with neonatal lupus and their unaffected siblings.
    Martin V; Lee LA; Askanase AD; Katholi M; Buyon JP
    Arthritis Rheum; 2002 Sep; 46(9):2377-83. PubMed ID: 12355485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibody syndrome and autoimmune diseases.
    Ostrowski RA; Robinson JA
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):53-65, vi. PubMed ID: 18207065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous lupus erythematosus: update of therapeutic options part I.
    Kuhn A; Ruland V; Bonsmann G
    J Am Acad Dermatol; 2011 Dec; 65(6):e179-93. PubMed ID: 20739095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical relevance of antiphospholipid antibodies in rheumatology].
    Gromnica-Ihle E; Franz J
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):525-9. PubMed ID: 7856256
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antimalarials in lupus erythematosus treatment].
    Woźniacka A
    Przegl Lek; 2002; 59(3):179-82. PubMed ID: 12184034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palindromic rheumatism: a response to chloroquine.
    Youssef W; Yan A; Russell AS
    J Rheumatol; 1991 Jan; 18(1):35-7. PubMed ID: 2023196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.